Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE study

AIM: To evaluate the effect of canagliflozin, a sodium‐glucose co‐transporter‐2 (SGLT2) inhibitor, on albuminuria and the decline of estimated glomerular filtration rate (eGFR) in participants with type 2 diabetes and microalbuminuria. METHODS: The CANPIONE study is a multicentre, randomized, parall...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyamoto, Satoshi, Heerspink, Hiddo J. L., de Zeeuw, Dick, Toyoda, Masao, Suzuki, Daisuke, Hatanaka, Takashi, Nakamura, Tohru, Kamei, Shinji, Murao, Satoshi, Hida, Kazuyuki, Ando, Shinichiro, Akai, Hiroaki, Takahashi, Yasushi, Koya, Daisuke, Kitada, Munehiro, Sugano, Hisashi, Nunoue, Tomokazu, Nakamura, Akihiko, Sasaki, Motofumi, Nakatou, Tatsuaki, Fujimoto, Kei, Kawanami, Daiji, Wada, Takashi, Miyatake, Nobuyuki, Yoshida, Michihiro, Shikata, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Clinical Study Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545385/
https://www.ncbi.nlm.nih.gov/pubmed/35491532
http://dx.doi.org/10.1111/dom.14731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545385/
https://www.ncbi.nlm.nih.gov/pubmed/35491532
http://dx.doi.org/10.1111/dom.14731

Ejemplares similares